Two different classes of bioadhesive excipients which have been approv
ed by the FDA, the anionic charged poly (acrylic acid) derivatives and
the cationic charged chitosans, have been investigated with respect t
o their ability to improve intestinal peptide drug absorption. It was
found that both polycarbophil and the chitosan derivatives Daichitosan
(R) VH and chitosan-glutamate (SeaCure(R) +210) enhance the absorption
of the peptide drug 9-desglycinamide, 8-arginine vasopressin (DGAVP)
in the vertically perfused intestinal loop model of the rat. Recent st
udies demonstrated that the two poly(acrylates) polycarbophil and Carb
opol(R) 934P are able to inhibit the activity of the proteolytic enzym
e trypsin at pH 6.7, which may lead to an increased stability of the p
eptide drug in the intestine. The depletion of Ca2+ out of the incubat
ion medium due to the Ca2+ binding properties of the poly (acrylates)
is discussed as a possible mechanism of action. Because of the observa
tion that depletion of Ca2+ can additionally cause an opening of tight
junctions, the influence of polycarbophil on the paracellular integri
ty of Caco-2 monolayers was also investigated by measurements of trans
epithelial electrical resistance (TEER) as well as by visualization st
udies using confocal laser scanning microscopy. At pH 4.0, apically ap
plied polycarbophil tended to decrease TEER values stronger than the c
ontrol solution, whereas at pH 7.0 no pronounced changes of TEER could
be observed. At pH 7.4, polycarbophil was only able to increase the p
aracellular permeability of the hydrophilic model compound fluorescein
-isothiocyanate-dextran (M(W) 4000) when applied to the basolateral si
de of the Caco-2 cell monolayer. In conclusion, bioadhesive polymers a
re promising absorption promoting agents for peroral delivery of pepti
de drugs, and their mechanism of action is probably a combination of i
nhibiting protease activities and modulating the intestinal epithelial
permeability.